Adapalene vs Cysteamine

Adapalene: Prevents clogged pores and treats inflammatory and non-inflammatory acne. Cysteamine: Can reduce melasma pigmentation in tested topical formulas.

Research updated 2026-10-25
Five adapalene gel 0.1% tubes and boxes lined up on white, including Differin, Effaclar, PanOxyl and NeutrogenaFour cysteamine products: a Senté tube, an Omic+ cream and box, a 5% cysteamine serum dropper and a Cyspera bottle

Which one is right for you?

Choose Adapalene if…

Choose for clogged pores and ongoing acne prevention; introduce gradually.

  • Blackheads, whiteheads and pimples
  • You want an over-the-counter retinoid
  • You can introduce it slowly at night

Choose Cysteamine if…

Consider for diagnosed melasma when a suitable topical option is needed.

  • Diagnosed melasma
  • Hydroquinone isn’t suitable
  • You can follow short-contact wash-off
Use care together

Can you use both?

Both can irritate. Cysteamine is a short-contact cream; keep it and adapalene on different times of day and build up slowly.

At a glance

● Adapalene
● Cysteamine
Type
Topical retinoid acne medicine
Pigment-targeting active
What it does
Prevents clogged pores and treats inflammatory and non-inflammatory acne.
Can reduce melasma pigmentation in tested topical formulas.
Best for
Acne; Post-Inflammatory Hyperpigmentation
Melasma
Studied concentrations
0.1% is available without prescription in the US; 0.3% is prescription.
5% cream in controlled melasma trials; contact instructions vary by product.
When to use
At night; introduce gradually according to the product label.
On the schedule specified for the product or prescribed treatment.
Time to results
Assess over roughly 3 months; photoaging can take longer
Usually assessed over 8–16 weeks
Irritation
Dryness, stinging and peeling can occur, especially early in use.
Odour, stinging and irritation may limit use; follow wash-off instructions.
Sensitive skin
Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.
Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.
Available
0.1% OTC and 0.3% prescription in the US; follow age restrictions.
Prescription or cosmetic status depends on the active, formula and country; check the label.

What it helps

Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.

Evidence level
Adapalene
Cysteamine
Strong evidenceMost established uses
Inflamed acne on light skin. The spots sit in a patch of pink, and the ring of redness around each one is easy to see. A few have a yellow-white head, and the skin between them is dry and flaking.

Acne

A guideline-supported treatment for comedones and inflammatory lesions.
—
Moderate evidenceSome supportive research
—
Flat tan patches with soft irregular edges across the forehead and upper cheek of an adult with light skin, the surface completely smooth.

Melasma

A placebo-controlled trial found reduced pigmentation with 5% cream.
Limited evidenceEarly or small studies
Flat light-brown residual marks on a fair cheek.

Post-Inflammatory Hyperpigmentation

Controlling acne may reduce new marks; established pigment can need additional care.
—
Insufficient evidence
The back of an upper arm on light skin, covered in small rough bumps at every hair opening. Each bump sits in a faint pink ring, so the arm looks evenly speckled and slightly red.

Keratosis Pilaris

The reviewed sources do not establish this ingredient as a treatment for this concern.
Redness and fine superficial vessels across a light-skinned cheek and nose.

Rosacea

The reviewed sources do not establish this ingredient as a treatment for this concern.
Extreme close-up of light skin in an active eczema flare, too close to tell which part of the body it is. Blotchy pink-red inflammation covers the whole frame with no clear edge, with small raised bumps, fine dry scale and a few fresh scratch marks.

Eczema

The reviewed sources do not establish this ingredient as a treatment for this concern.
Flat light-brown residual marks on a fair cheek.

Post-Inflammatory Hyperpigmentation

The cited melasma trial does not establish fading of every type of dark mark.
The front of a forearm on fair skin. Two pale patches with sharp edges sit against lightly tanned skin, and the difference between the patch and the skin around it is subtle.

Vitiligo

The reviewed sources do not establish this ingredient as a treatment for this concern.
Sensitive Skin on light skin.

Sensitive Skin

The reviewed sources do not establish this ingredient as a treatment for this concern.
How it works

Adapalene

Adapalene mechanism diagram. Binds retinoid receptors: Adapalene works without conversion to retinoic acid. Helps keep follicles clear: Regulates cell shedding and inflammatory pathways.
Open full-size diagram
Diagram explanation and sources

Binds retinoid receptors: Adapalene works without conversion to retinoic acid. Helps keep follicles clear: Regulates cell shedding and inflammatory pathways.

Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.

Source 1 · Source 2 · Source 3

Cysteamine

Cysteamine mechanism diagram. Affects melanin formation: Cysteamine acts through several pigment pathways. May help melasma: The formula, contact time and tolerance matter.
Open full-size diagram
Diagram explanation and sources

Affects melanin formation: Cysteamine acts through several pigment pathways. May help melasma: The formula, contact time and tolerance matter.

Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.

Source 1

Using both in one routine

Built from where each one usually sits in a routine. Introduce one at a time.

Morning
Step 1
Cleanser
Step 2
Moisturizer
Step 3
Sunscreen
Night
Step 1
Cleanser
Step 2
AdapaleneNight
Step 3
CysteamineNight
Step 4
Moisturizer

Strengths and forms

Concentrations

Adapalene is a medicine, not a cosmetic retinol. U.S. acne formulations include 0.1% and 0.3%; the higher strength is prescription.

0.1%

0.3%

OTC acne gel

A labeled acne treatment in the U.S. Improvement takes time; using extra product does not speed the result.

Prescription acne gel

A higher-strength formulation with comparative trial evidence. A clinician can weigh benefit against irritation.

Choosing a strength: Choose the medicine and vehicle for acne severity and tolerance. Adapalene percentages are not equivalent to retinol or retinaldehyde percentages.

Higher strengths: Dryness, peeling and irritation can occur. Do not step up strength or combine several retinoids just because improvement is slow.

Formula matters: Products combining adapalene with benzoyl peroxide have additional active ingredients and different labeling; read the whole product name.

5% cysteamine cream is the main concentration studied for melasma. Contact time is product-specific; some studied formulas are short-contact treatments rather than overnight creams.

5%

Studied melasma cream

Controlled trials studied this strength. One short-contact trial used a specific cream; follow the current product’s instructions rather than copying a study schedule.

Choosing a strength: Choose a finished topical product with clear instructions for how long to leave it on and when to rinse.

Higher strengths: There is no established benefit from escalating beyond the studied strength. Burning, redness or a persistent rash are reasons to stop and reassess.

Formula matters: Stabilization, the base cream and exposure time affect tolerability. Different cysteamine formulations need not have identical instructions.

Forms
Gel · Cream · Combination gel
Cream

When you’ll see results

Approximate windows, not promises.

● Adapalene
● Cysteamine
First few weeks

First few weeksDryness or irritation may occur; worsening is not required for benefit.

First few weeksAssess tolerance first; pigment change is usually slower.

4–8 weeks

4–8 weeksFewer new lesions may become noticeable.

4–8 weeksSome studied regimens begin showing pigment improvement.

8–12 weeks

8–12 weeksReassess acne control after a consistent course.

8–12 weeksA useful review point for benefit and irritation.

3–6 months

3–6 monthsMaintenance may help if the treatment works and remains comfortable.

3–6 monthsMany melasma trials assess results over three to four months; recurrence is common.

6–12 months

6–12 monthsContinue only if appropriate; scarring or persistent acne warrants reassessment.

6–12 monthsLong-term use depends on the active; follow a monitored plan rather than extending treatment automatically.

Safety and sensitive skin

Common reactions

Dryness, stinging and peeling can occur, especially early in use.

Odour, stinging and irritation may limit use; follow wash-off instructions.

When to stop

Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.

Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.

Sensitive or inflamed skin

Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.

Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.

Important limits

Follow the age and use restrictions on the label; OTC adapalene 0.1% is labelled for ages 12 and older in the US.

Do not use a cosmetic product as a substitute for diagnosis of an unexplained, changing or persistent skin problem.

Pregnancy

Retinoids are avoided in pregnancy and while trying to conceive.

Data in pregnancy are limited; ask the clinician managing your pregnancy before using.

How it works

In the skin

On the skin. The finished product delivers adapalene in a particular vehicle.

Entering skin. Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.

Conversion. Binds retinoid receptors directly; it does not need conversion into retinoic acid.

Skin response. Binds retinoid receptors directly, regulating follicular cell shedding and inflammatory pathways.

Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.

On the skin. The finished product delivers cysteamine in a particular vehicle.

Entering skin. Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.

Conversion. No activation step is established as necessary for its intended topical role.

Skin response. Acts on pigment-related pathways; the cream, contact time and tolerance influence its practical effect.

Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.

Getting in
Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.
Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.
Molecule size
Adapalene · 412 Da
Cysteamine · 77 Da
Smaller than 500 Da passes the outer skin more easily. Size isn’t an effectiveness score.
500 Da guideline

Common questions

Adapalene:What should I choose adapalene for?

Choose for clogged pores and ongoing acne prevention; introduce gradually.

Adapalene:How strong is the evidence?

Guidelines and controlled acne trials support adapalene. Evidence for acne medicines should not be transferred automatically to retinol, and irritation does not indicate greater benefit.

Cysteamine:What should I choose cysteamine for?

Consider for diagnosed melasma when a suitable topical option is needed.

Cysteamine:How strong is the evidence?

A small placebo-controlled study supports 5% cream over four months. Active-comparator studies are small and do not prove equal efficacy to hydroquinone. The mass shown refers to the free base, not its hydrochloride salt.

Sources

Sources and further reading

  1. Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study. (2007)
  2. Guidelines of care for the management of acne vulgaris. (2024)
  3. FDA adapalene 0.1% label
  4. Evaluation of the efficacy of cysteamine 5% cream in the treatment of epidermal melasma: a randomized double-blind placebo-controlled trial. (2015)
  5. Phase III comparison of 0.1% and 0.3% adapalene
  6. Short-contact 5% cysteamine clinical trial
Dermapedia on YouTube